Inodilator versus inotrope: do inodilators have an edge to improve outcome in patients with heart failure or cardiac dysfunction? [PDF]
, 2020 Numerous meta-analyses on inotropes (dobutamine) and inodilators (milrinone, levosimendan) suggest that their impact on survival are at best neutral (but may be deleterious) whereas levosimendan seems to have beneficial effects on survival in patients ...
Longrois, Dan +2 more
core +2 more sources
Hemodynamic and anti-inflammatory effects of early esmolol use in hyperkinetic septic shock. a pilot study [PDF]
, 2021 Background: Several studies have shown that heart rate control with selective beta-1 blockers in septic shock is safe. In these trials, esmolol was administered 24 h after onset of septic shock in patients who remained tachycardic.
Duarte K. +7 more
core +1 more source
Lupus myocarditis. Case report [PDF]
, 2005 Myocarditis is one of the many possible forms of cardiac involvement in systemic lupus erythematosus. Its clinical presentation ranges from asymptomatic patients with self-limited disease to fulminant heart failure that can lead to death.
Campos, M +9 more
core
Reversion of Severe Mitral Insufficiency in Peripartum Cardiomyopathy Using Levosimendan [PDF]
, 2020 Idiopathic peripartum cardiomyopathy presenting with heart failure is a true diagnostic and treatment challenge. Goal oriented clinical management aims at the relapse of left ventricular systolic dysfunction.
Bornacelli, Yamil E. Jaller +5 more
core +2 more sources
Beneficial impact of levosimendan in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials [PDF]
, 2015 INTRODUCTION: The incidence of Acute Kidney Injury is nowadays high in critically ill patients. Its etiology is multifactorial and a primary role is played by low cardiac output syndrome.
Belletti, A +12 more
core +1 more source
Therapeutic Development of Levosimendan in Acute and Advanced Heart Failure: A Systematic Review. [PDF]
Cureus, 2023 Desai HN +9 more
europepmc +1 more source
a retrospective analysis [PDF]
, 2014 Background Several animal studies suggest beneficial effects on kidney function upon administration of levosimendan. As recent data from clinical studies are heterogeneous, we sought to investigate whether levosimendan is associated with improved ...
Balzer, Felix +7 more
core +1 more source
Perioperative use of levosimendan in patients undergoing cardiac surgery: systematic review and meta-analysis [PDF]
, 2018 Introducción: Los pacientes llevados a cirugía cardiaca tienen riesgo de desarrollar síndrome de bajo gasto cardiaco posoper- atorio (SBGC). Estudios previos han encontrado una menor mortalidad con levosimendán respecto a placebo u otros inotrópicos; sin
Garcia, Hans +3 more
core +1 more source
Eficacia de la Dobutamina contra levosimendán para el tratamiento del choque cardiogénico: Una revisión sistemática [PDF]
El choque cardiogénico (ChC) está causado por un deterioro grave del funcionamiento miocárdico en el que, el gasto cardíaco (GC) es insuficiente para proporcionar una perfusión tisular adecuada, o es suficiente, pero requiere cambios hemodinámicos ...
Corpus Badillo, Roberto
core
Inotropes and inodilators for acute heart failure: sarcomere active drugs in focus [PDF]
, 2017 Nagy, László +2 more
core +1 more source